GOLDMAN SACHS GROUP INC - MEDGENICS INC ownership

MEDGENICS INC's ticker is MDGN and the CUSIP is 58436Q203. A total of 53 filers reported holding MEDGENICS INC in Q3 2015. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of MEDGENICS INC
ValueSharesWeighting
Q3 2016$130,000
+39.8%
23,333
+39.8%
0.00%
Q2 2016$93,000
+40.9%
16,692
+11.1%
0.00%
Q1 2016$66,000
-17.5%
15,018
+13.5%
0.00%
Q4 2015$80,000
-26.6%
13,232
-5.1%
0.00%
Q3 2015$109,000
-38.1%
13,941
-36.2%
0.00%
Q1 2015$176,00021,8620.00%
Other shareholders
MEDGENICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,058,400$8,277,0004.07%
Belmont Global Advisors, Inc. 155,000$1,212,0002.06%
Broadfin Capital, LLC 1,545,306$12,084,0000.67%
CARL DOMINO INC 34,134$267,0000.21%
QVT Financial LP 267,608$2,093,0000.07%
WHITE PINE CAPITAL LLC 20,000$156,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 119,000$931,0000.02%
HYMAN CHARLES D 13,000$102,0000.02%
Kavar Capital Partners, LLC 1,500$11,0000.01%
Brick & Kyle, Associates 1,000$8,0000.01%
View complete list of MEDGENICS INC shareholders